cassavasciences
SAVA stock looks poised to regain YTD decline as investors see potential of biopharma’s Alzheimer’s disease treatment Shares of Austin, Texas-based neuroscience biopharma company Cassava Sciences Inc (NASDAQ:SAVA) surged 11.73% in extended trading after a Form 4 filing disclosed an independent board director made a significant purchase in the post-fourth quarter results trading window. Q4 2022 hedge fund letters, conferences and more Find A Qualified Financial AdvisorEach advisor has been vetted by SmartAsset and is held to a fiduciary standard to act in your best interests. If you're ready to...
ValueWalk
Whitney Tilson’s email to investors discussing Hard Money’s Million Dollar Podcast up more than 10x; why he no longer short stocks; Cassava Sciences Inc (NASDAQ:SAVA); Nikola Corporation (NASDAQ:NKLA); Zillow Group Inc (NASDAQ:ZG). Q3 2021 hedge fund letters, conferences and more Hard Money's Million Dollar Podcast Up More Than 10x1) I want to give a shout-out to my colleagues Enrique Abeyta and Gabe Marshank, who are crushing it with their Hard Money's Million Dollar Podcast, which follows them as they try to turn $10,000 into $1 million – or go bust trying. It's a total balls-to-the-wall app...
ValueWalk
Whitney Tilson’s email to investors discussing Gabriel Grego’s short report on Cassava Sciences Inc (NASDAQ:SAVA); retail sales rise, showing strong consumer demand, higher inflation; China’s economy rests on three shaky legs; Pivot podcast by Kara Swisher and Scott Galloway; his Zoom call on The Art of Playing Defense. Q3 2021 hedge fund letters, conferences and more Gabriel Grego's Short Report On Cassava Sciences1) My friend and former student Gabriel Grego of Quintessential Capital Management just released a short report on Cassava Sciences (SAVA). The biotech company has a $2.3 billion ma...
ValueWalk
閲覧を続けるには、ノアドット株式会社が「プライバシーポリシー」に定める「アクセスデータ」を取得することを含む「nor.利用規約」に同意する必要があります。
「これは何?」という方はこちら